<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We investigated the neuroprotective effect of infusing various doses of clomethiazole in models of global and focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In a model of global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, gerbils were infused with clomethiazole (intravenous), attaining steady state plasma concentrations of between 1 and 13 microM for 24 h </plain></SENT>
<SENT sid="2" pm="."><plain>In a transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model in rats, clomethiazole was administered subcutaneously over 22.75 h using osmotic minipumps producing steady state plasma concentrations of between 1 and 13 microM </plain></SENT>
<SENT sid="3" pm="."><plain>Clomethiazole was protective in these models at plasma concentrations of respectively 6.1 microM and above and 3.5 microM and above </plain></SENT>
<SENT sid="4" pm="."><plain>Clomethiazole is thus neuroprotective in both global and focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> at plasma concentrations known to be well tolerated in <z:hpo ids='HP_0001297'>stroke</z:hpo> patients </plain></SENT>
</text></document>